logo 5240 1 mg
Pill imprint logo 5240 1 mg has been identified as Anagrelide hydrochloride 1 mg.
Anagrelide is used in the treatment of thrombocythemia; chronic myelogenous leukemia and belongs to the drug class miscellaneous uncategorized agents. Risk cannot be ruled out during pregnancy.
Anagrelide 1 mg is not subject to the Controlled Substances Act.
See also related documents.
Anagrelide hydrochloride Images
- Imprint:
-
logo 5240
1 mg - Strength:
- 1 mg
- Color:
- White
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Inactive Ingredients:
- microcrystalline cellulose
crospovidone
D&C Yellow No. 10
FD&C Blue No. 1
FD&C Blue No. 2
FD&C Red No. 40
ferrosoferric oxide
gelatin
lactose anhydrous
lactose monohydrate
magnesium stearate
povidone
propylene glycol
titanium dioxide
- Drug Class:
- Miscellaneous uncategorized agents
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Teva Pharmaceuticals USA
- National Drug Code (NDC):
- 00172-5240
More Anagrelide Hydrochloride resources
- Anagrelide (Wolters Kluwer)
- anagrelide (Cerner Multum)
- anagrelide (Micromedex) - Includes Dosage Information
- Anagrelide hydrochloride (AHFS DI)
- Anagrelide (FDA)
- Anagrelide (Wolters Kluwer)


